what is a microdose of retatrutide vs tirzepatide for weight loss ⚠️ Stop microdosing Retatrutide, it's

Your provider will monitor tolerability, glycemic response (if applicable), and weight loss trajectory over 8-12 weeks before dose escalation

Frequently Asked Questions Everything you need to know What is Retatrutide?+ Retatrutide is an injectable weight-loss and diabetes drug developed by Eli Lilly , currently in Phase 3 clinical trials

Michel MC, Brunner HR, Foster C, Huo Y (2016) Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease

How may GIP enhance the therapeutic efficacy of GLP-1

Nausea, constipation, and decreased appetite are most common, particularly during dose titration

Tirzepatide, the active ingredient in Mounjaro, is EMA-approved and has shown weight loss of 15 to 22% in studies, bringing it closest to retatrutide of all current options